Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Other Non-Current Assets (2021 - 2026)

Zymeworks (ZYME) posted Other Non-Current Assets of $6.7 million for Q1 2026, little changed sequentially from $6.7 million in Q4 2025, and down 26.87% YoY from $9.1 million in Q1 2025.

Analysis

Zymeworks (ZYME) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Zymeworks has reported Other Non-Current Assets for 6 years, with the latest figure at $6.7 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 26.87% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 26.87% YoY) and the FY2025 annual result came in at $6.7 million, down 25.17% from the prior year.
  • Other Non-Current Assets was little changed at $6.7 million in Q1 2026 per ZYME's latest filing, from $6.7 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $16.9 million in Q1 2023 and troughed at $6.7 million in Q1 2026.
  • A 5-year average of $9.5 million and a median of $7.9 million in 2023 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets increased 25.93% in 2022, then tumbled 54.54% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $15.7 million in 2022, then slumped by 51.9% to $7.6 million in 2023, then advanced by 17.88% to $8.9 million in 2024, then decreased by 25.17% to $6.7 million in 2025, then fell by 0.33% to $6.7 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $6.7 million, $6.7 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Zymeworks 2.13 Bn 1.86 Bn - 2.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.28 Mn
Mar 31, 2026 6.65 Mn
Dec 31, 2025 6.67 Mn
Sep 30, 2025 7.39 Mn
Jun 30, 2025 8.86 Mn
Mar 31, 2025 9.10 Mn
Dec 31, 2024 8.92 Mn
Sep 30, 2024 7.23 Mn
Jun 30, 2024 7.18 Mn
Mar 31, 2024 7.68 Mn
Dec 31, 2023 7.57 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 7.91 Mn
Mar 31, 2023 16.89 Mn
Dec 31, 2022 15.73 Mn
Sep 30, 2022 16.45 Mn
Dec 31, 2021 12.49 Mn